Shipping ADCs with Confidence: Eliminating the Risks That Keep Program Leaders Up at Night
Antibody-drug conjugates (ADCs) represent some of the most promising, and most complex, therapies in...
read Details
In this video, Engineering Managers Carson Dickey and Rob Battista break down each of ISTA’s recommendations in PCG-03 and discuss how you can implement them in your cold chain strategy.
During this 45-minute pre-recorded webinar, you will learn:
Antibody-drug conjugates (ADCs) represent some of the most promising, and most complex, therapies in...
read Details
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details